Clinical Trials Directory

Trials / Completed

CompletedNCT04745364

Mindful Kala: Virtual Bharatanatyam Wellness Program for Students

Mindful Kala: Investigating the Psychosocial Effects of a 4-Week Virtual Bharatanatyam Intervention for Students

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

In the current study, the researchers propose to develop and pilot test a Bharatanatyam (i.e. Indian classical dance) program called Mindful Kala with the hopes of decreasing stress and increasing psychosocial well-being, mindfulness, cultural competence, and connectedness amongst a group of college students. The investigators hope that this program can help students cultivate well-being during the challenging and stressful time of COVID-19.

Detailed description

Objectives: 1. Evaluate the effects of the Mindful Kala program on outcomes of health-related measures such as mindfulness, stress, connectedness, and wellbeing amongst students. The investigators hypothesize that participants will experience fewer symptoms of stress, increased mindfulness, increased well-being, and increased connectedness. 2. Evaluate the effects of the Mindful Kala program on changes in measures of cultural competence. The investigators hypothesize that the level of cultural competence will increase among the students. 3. Develop and examine the feasibility and acceptability of a 4-week Mindful Kala program for college students.

Conditions

Interventions

TypeNameDescription
BEHAVIORALA 4-week Bharatanatyam course from the organization Mindful KalaThe 4-week Mindful Kala program focuses on three components of Bharatanatyam: nritta (i.e. technical movements), natya (i.e. storytelling), and nritya (i.e. a combination of movements and narration; nritta + natya).

Timeline

Start date
2021-02-04
Primary completion
2021-04-12
Completion
2021-04-12
First posted
2021-02-09
Last updated
2021-06-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04745364. Inclusion in this directory is not an endorsement.